This unique book brings together a series of topical discussions of how the new immunotherapeutic agents can be used successfully to treat lymphoid malignancies. The contributors are prestigious clinicians and researchers working at the cutting edge of the field. This will be an invaluable resource for haematologists or oncologists. They will find up-to-date data and clinical advice regarding the latest immunotherapeutic options in haematology.